NCI Community Oncology Research Program Minority Underserved Community Sites
NCI 社区肿瘤学研究计划少数群体服务不足的社区站点
基本信息
- 批准号:8900255
- 负责人:
- 金额:$ 138.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAfrican AmericanAmerican IndiansAsiansAwarenessBeautyCancer CenterCancer PatientCatchment AreaCensusesCharacteristicsClinical ResearchClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCommunity Clinical Oncology ProgramCountyEnrollmentGeographic LocationsHawaiian populationHealth Services AccessibilityHealthcare SystemsHispanicsHospitalsImprove AccessIncidenceIncomeIndustryJointsLatinoLeadershipLifeMalignant NeoplasmsMexicanMinority GroupsNCI-Designated Cancer CenterNational Clinical Trials NetworkNew MexicoNot Hispanic or LatinoOncologistOutcomePatientsPatternPersonsPhysiciansPopulationPovertyPreventionPublic HospitalsRaceReportingResearchResearch PersonnelScreening for cancerSiteTherapeutic Clinical TrialUnderrepresented MinorityUnderserved PopulationUninsuredUnited StatesUniversitiesWomanWorkanticancer researchbasecancer carecancer educationcancer health disparitycancer preventioncare deliverycommunity based participatory researchethnic minority populationexperiencehealth disparityimprovedmortalityprogramsrural areascreeningsocioeconomic disparitysuccess
项目摘要
DESCRIPTION (provided by applicant): As the Official Cancer Center of the State of New Mexico and as one of the nation's NCI-Designated Cancer Centers (2P30CA118100-09), the UNMCC has built collaborative partnerships with community oncologists and healthcare systems throughout the State of New Mexico to create the New Mexico Cancer Care Alliance (NMCCA), a joint 501c3 statewide cancer clinical trials organization and clinical research network. Through both these collaborative partnerships, UNMCC has worked to improve the quality of cancer care in our region; to enhance community-based cancer education, screening, and prevention; to promote community based participatory research; and to increase awareness, access and participation of all New Mexicans in NCl sponsored cancer screening, prevention and therapeutic clinical trials. The sites detailed herein which have worked together for 13 years to enroll New Mexico's highly diverse multiethnic and frequently underserved cancer patients on NCI Cooperative Group trials, as well as investigator initiated and industry trials; plan to continue this collaboration as the New Mexico NCI Community Oncology Research Program Minority/Underserved (NM NCORP). The NM NCORP has a catchment area for both the clinical trials program and the cancer care delivery research that includes the entire
State. With a higher percentage of Hispanics and American Indians than any other state, New Mexico's 2.0 million citizens are 40.5% non-Hispanic White, 46.3% Hispanic, 9.4% American Indian, 2.1 % Black and the remainder is Asian & other ethnic minorities. New Mexicans experience unusual cancer patterns and tremendous cancer health disparities. New Mexico is ranked 43rd in the United States for per capita income. According to the 2011 Census Bureau 18.4% of New Mexicans live below the poverty level well above the national average of 13%. Over 50% of New Mexicans live in rural areas of the State with often limited access to healthcare and 22.9% of New Mexicans are uninsured (ranging from 4.8% to 31.6% among the different New Mexico counties). Of the patients accrued to cancer clinical trials at the UNMCC in 2012, 51% were racial/ethnic minorities (37.3% Hispanic/Latino, 8.2% American Indian, 2.1% African American, 1.1% Asian persons, 1.1% Native Hawaiians, and 1.1% reporting (two or more races) and 55% were women.
描述(由申请人提供):作为新墨西哥州的官方癌症中心和国家 NCI 指定癌症中心之一 (2P30CA118100-09),UNMCC 与全州的社区肿瘤学家和医疗保健系统建立了合作伙伴关系新墨西哥州创建新墨西哥州癌症护理联盟 (NMCCA),这是一个联合 501c3 全州癌症临床试验组织和临床研究网络。通过这两个合作伙伴关系,UNMCC 致力于提高我们地区的癌症护理质量;加强以社区为基础的癌症教育、筛查和预防;促进基于社区的参与性研究;提高所有新墨西哥人对 NCl 赞助的癌症筛查、预防和治疗临床试验的认识、参与和参与。本文详述的这些站点已合作 13 年,将新墨西哥州高度多样化的多种族且经常得不到充分服务的癌症患者纳入 NCI 合作组试验以及研究者发起的行业试验;计划作为新墨西哥州 NCI 社区肿瘤学研究计划少数民族/服务不足 (NM NCORP) 继续开展这种合作。新墨西哥州 NCORP 拥有一个用于临床试验项目和癌症护理提供研究的服务区域,其中包括整个项目
状态。新墨西哥州的西班牙裔和美洲印第安人比例高于任何其他州,其 200 万公民中 40.5% 为非西班牙裔白人,46.3% 为西班牙裔,9.4% 为美洲印第安人,2.1% 为黑人,其余为亚洲人和其他少数族裔。新墨西哥人经历着不寻常的癌症模式和巨大的癌症健康差异。新墨西哥州的人均收入在美国排名第 43 位。根据 2011 年人口普查局的数据,18.4% 的新墨西哥人生活在贫困线以下,远高于 13% 的全国平均水平。超过 50% 的新墨西哥人生活在该州的农村地区,获得医疗保健的机会往往有限,22.9% 的新墨西哥人没有保险(新墨西哥州不同县的比例从 4.8% 到 31.6% 不等)。 2012 年参加 UNMCC 癌症临床试验的患者中,51% 是少数种族/族裔(37.3% 西班牙裔/拉丁裔、8.2% 美洲印第安人、2.1% 非裔美国人、1.1% 亚洲人、1.1% 夏威夷原住民和 1.1% % 报告(两个或多个种族),55% 为女性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROLYN Y MULLER其他文献
CAROLYN Y MULLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROLYN Y MULLER', 18)}}的其他基金
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
- 批准号:
10678911 - 财政年份:2014
- 资助金额:
$ 138.36万 - 项目类别:
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
- 批准号:
10227003 - 财政年份:2014
- 资助金额:
$ 138.36万 - 项目类别:
Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Ovarian Cancer
腹腔内腺病毒 p53 基因治疗卵巢癌的 I 期试验
- 批准号:
6975048 - 财政年份:2004
- 资助金额:
$ 138.36万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6567625 - 财政年份:2001
- 资助金额:
$ 138.36万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6414473 - 财政年份:2000
- 资助金额:
$ 138.36万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6265031 - 财政年份:1998
- 资助金额:
$ 138.36万 - 项目类别:
相似海外基金
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
来自不同受影响祖先群体的住院 COVID-19 患者的时间转录组学用于治疗发现
- 批准号:
10661693 - 财政年份:2021
- 资助金额:
$ 138.36万 - 项目类别:
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
来自不同受影响祖先群体的住院 COVID-19 患者的时间转录组学用于治疗发现
- 批准号:
10442561 - 财政年份:2021
- 资助金额:
$ 138.36万 - 项目类别:
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
来自不同受影响祖先群体的住院 COVID-19 患者的时间转录组学用于治疗发现
- 批准号:
10298801 - 财政年份:2021
- 资助金额:
$ 138.36万 - 项目类别:
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
来自不同受影响祖先群体的住院 COVID-19 患者的时间转录组学用于治疗发现
- 批准号:
10298801 - 财政年份:2021
- 资助金额:
$ 138.36万 - 项目类别:
Columbia Center for Interdisciplinary Research on Alzheimer's Disease Disparities (CIRAD)
哥伦比亚阿尔茨海默病差异跨学科研究中心 (CIRAD)
- 批准号:
10231023 - 财政年份:2018
- 资助金额:
$ 138.36万 - 项目类别: